Aurora Cannabis (NYSE:ACB)‘s stock had its “sell” rating reissued by investment analysts at Stifel Nicolaus in a note issued to investors on Thursday, The Fly reports. They presently have a $5.00 price target on the stock, down from their previous price target of $7.00. Stifel Nicolaus’ target price indicates a potential downside of 15.97% from the company’s current price.
A number of other research firms also recently commented on ACB. Compass Point initiated coverage on Aurora Cannabis in a report on Monday, July 8th. They set a “neutral” rating for the company. Zacks Investment Research raised Aurora Cannabis from a “sell” rating to a “hold” rating in a report on Thursday. ValuEngine raised Aurora Cannabis from a “hold” rating to a “buy” rating in a report on Wednesday, August 21st. Bank of America downgraded Aurora Cannabis from a “buy” rating to a “neutral” rating and set a $7.30 target price for the company. in a report on Thursday, July 18th. Finally, Piper Jaffray Companies set a $7.00 target price on Aurora Cannabis and gave the stock a “hold” rating in a report on Friday. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Aurora Cannabis currently has a consensus rating of “Buy” and an average target price of $8.23.
Aurora Cannabis stock opened at $5.95 on Thursday. The company has a quick ratio of 1.98, a current ratio of 1.52 and a debt-to-equity ratio of 0.09. Aurora Cannabis has a 52 week low of $4.58 and a 52 week high of $12.52. The company has a market capitalization of $6.01 billion, a price-to-earnings ratio of -27.05 and a beta of 2.47. The stock has a 50-day moving average price of $6.06 and a 200 day moving average price of $7.66.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Featured Article: Dividend Aristocrat Index
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.